Estimate Recalculated Nov 8, 2024 09:38PM EST
Stephen A Sherwin has an estimated net worth of $29.6 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., NEUROCRINE BIOSCIENCES INC, BIOSANTE PHARMACEUTICALS INC, Verastem, Inc., ADURO BIOTECH, INC., Neon Therapeutics, Inc., BioPlus Acquisition Corp., RIGEL PHARMACEUTICALS INC, VICAL INC, Epiphany Technology Acquisition Corp., and CELL GENESYS INC.
Stephen A Sherwin's CIK is 0001079462
2004 was Stephen A Sherwin's most active year for acquiring shares with 12 total transactions. Stephen A Sherwin's most active month to acquire stocks was the month of April. 2009 was Stephen A Sherwin's most active year for disposing of shares, totalling 16 transactions. Stephen A Sherwin's most active month to dispose stocks was the month of September. 2024 saw Stephen A Sherwin paying a total of $1,787,350.00 for 48,408 shares, this is the most they've acquired in one year. In 2024 Stephen A Sherwin cashed out on 84,199 shares for a total of $5,338,564.50, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!